Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

prulifloxacin MeSH Supplementary Concept Data 2025


MeSH Supplementary
prulifloxacin
Unique ID
C074191
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C074191
Entry Term(s)
6-fluoro-1-methyl-7-(4-(5-methyl-2-oxo-1,3-dioxelen-4-yl)methyl-1-piperazinyl)-4-oxo-4H-(1,3)thiazeto(3,2-a)quinoline-3-carboxylic acid
NM 441
NM-441
NM441
Pharm Action
Anti-Bacterial Agents
Topoisomerase II Inhibitors
Registry Numbers
J42298IESW
Related Numbers
123447-62-1
CAS Type 1 Name
1H,4H-(1,3)Thiazeto(3,2-a)quinoline-3-carboxylic acid, 6-fluoro-1-methyl-7-(4-((5-methyl-2-oxo-1,3-dioxol-4-yl)methyl)-1-piperazinyl)-4-oxo-
Previous Indexing
*QUINOLONES (1992-2008)
Heading Mapped to
*Dioxolanes
*Piperazines
*Fluoroquinolones
Frequency
112
Note
structure given in first source
Source
Antimicrob Agents Chemother 1991 Dec;35(12):2496-9
Date of Entry
1992/05/25
Revision Date
2013/05/22
prulifloxacin Preferred
NM-441 Narrower
page delivered in 0.004s